Cytotoxic T lymphocyte activation by cross-priming-Reference-Cited by-同舟云学术

Cytotoxic T lymphocyte activation by cross-priming

Published:1999-06 Issue:3 Volume:11 Page:314-318
ISSN:0952-7915
Container-title:Current Opinion in Immunology
language:en
Short-container-title:Current Opinion in Immunology

Author:

Heath William R,Carbone Francis R

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference14 articles.

1. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming;Bevan;J Immunol,1976

2. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not crossreact in the cytotoxic assay;Bevan;J Exp Med,1976

3. Constitutive class l-restricted exogenous presentation of self antigens in vivo;Kurts;J Exp Med,1996

4. CD4+ T cell tolerance to parenchymal self antigens requires presentation by bone marrow derived antigen presenting cells;Adler;J Exp Med,1998

5. Class I-restricted cross-presentation of exogenous self antigens leads to deletion of autoreactive CD8+ T cells;Kurts;J Exp Med,1997

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathways of Antigen Recognition by T Cells in Allograft Rejection;Transplantation;2022-11-10

2. The Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes;Frontiers in Immunology;2018-11-05

3. Bone marrow-derived inflammatory and steady state DCs are different in both functions and survival;Cellular Immunology;2018-09

4. Immune Properties of HSP70;HSP70 in Human Diseases and Disorders;2018

5. The development of dendritic cell vaccine-based immunotherapies for glioblastoma;Seminars in Immunopathology;2017-01-30